Literature DB >> 8011621

Crystal structure of unmodified tRNA(Gln) complexed with glutaminyl-tRNA synthetase and ATP suggests a possible role for pseudo-uridines in stabilization of RNA structure.

J G Arnez1, T A Steitz.   

Abstract

tRNA(2Gln) made in vitro by transcription with T7 RNA polymerase does not contain the pseudouridines at positions 38, 39, and 55, the 4-thiouridine at position 8, or any of the methylated bases found in the tRNA(2Gln) made in vivo. Cocrystals of unmodified tRNA(2Gln) complexed with glutaminyl-tRNA synthetase from Escherichia coli are isomorphous with those of the complex with modified tRNA(2Gln). A difference electron density map between the complexes with modified and unmodified tRNAs calculated at 2.5-A resolution shows no differences in the protein or tRNA structures, except for some very small shifts in atoms contacting the thiol at the 4 position of uridine 8 that are required to accommodate the smaller oxygen in the unmodified tRNA. Perhaps the most functionally significant change in the unmodified tRNA is the absence of the specifically bound water molecules that are observed to cross-link the N5 of the pseudo-uridines to their 5' phosphate. This suggests a possible role for pseudouridinylation in stabilization of the tRNA through water-mediated linking of these modified bases to the backbone, which is consistent with the lower thermal stability of the unmodified tRNA. An identical water-bridging structure is possible at four of the five other psuedo-uridines in known tRNA structures.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8011621     DOI: 10.1021/bi00190a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  105 in total

1.  An engineered class I transfer RNA with a class II tertiary fold.

Authors:  T A Nissan; B Oliphant; J J Perona
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

2.  Alternative designs for construction of the class II transfer RNA tertiary core.

Authors:  T A Nissan; J J Perona
Journal:  RNA       Date:  2000-11       Impact factor: 4.942

3.  Chemical and enzymatic synthesis of tRNAs for high-throughput crystallization.

Authors:  L D Sherlin; T L Bullock; T A Nissan; J J Perona; F J Lariviere; O C Uhlenbeck; S A Scaringe
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

4.  Methylation of the ribosyl moiety at position 34 of selenocysteine tRNA[Ser]Sec is governed by both primary and tertiary structure.

Authors:  L K Kim; T Matsufuji; S Matsufuji; B A Carlson; S S Kim; D L Hatfield; B J Lee
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

5.  Kinetics of tRNA folding monitored by aminoacylation.

Authors:  Hari Bhaskaran; Annia Rodriguez-Hernandez; John J Perona
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

6.  Glycosidic bond conformation preference plays a pivotal role in catalysis of RNA pseudouridylation: a combined simulation and structural study.

Authors:  Jing Zhou; Chao Lv; Bo Liang; Mengen Chen; Wei Yang; Hong Li
Journal:  J Mol Biol       Date:  2010-07-06       Impact factor: 5.469

7.  Mass spectrometry-based quantification of pseudouridine in RNA.

Authors:  Balasubrahmanyam Addepalli; Patrick A Limbach
Journal:  J Am Soc Mass Spectrom       Date:  2011-05-03       Impact factor: 3.109

Review 8.  Functions and mechanisms of spliceosomal small nuclear RNA pseudouridylation.

Authors:  Guowei Wu; Andrew T Yu; Athena Kantartzis; Yi-Tao Yu
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-02-18       Impact factor: 9.957

9.  Arabidopsis CBF5 interacts with the H/ACA snoRNP assembly factor NAF1.

Authors:  Inna Lermontova; Veit Schubert; Frederik Börnke; Jiri Macas; Ingo Schubert
Journal:  Plant Mol Biol       Date:  2007-08-22       Impact factor: 4.076

10.  Evolving insights into RNA modifications and their functional diversity in the brain.

Authors:  Sarah Nainar; Paul R Marshall; Christina R Tyler; Robert C Spitale; Timothy W Bredy
Journal:  Nat Neurosci       Date:  2016-09-27       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.